2018 Q1 Form 10-Q Financial Statement

#000114420418036123 Filed on June 27, 2018

View on sec.gov

Income Statement

Concept 2018 Q1 2017 Q4 2017 Q1
Revenue $86.69K $70.00K $0.00
YoY Change
Cost Of Revenue $1.036M $950.0K $0.00
YoY Change
Gross Profit -$949.0K -$880.0K $0.00
YoY Change
Gross Profit Margin -1094.79% -1257.14%
Selling, General & Admin $2.530M $1.080M $940.0K
YoY Change 169.15% -30.32% 1242.86%
% of Gross Profit
Research & Development $90.40K $10.00K $64.02K
YoY Change 41.21% -97.56%
% of Gross Profit
Depreciation & Amortization $5.630K $290.0K $881.00
YoY Change 539.05%
% of Gross Profit
Operating Expenses $2.623M $1.090M $1.005M
YoY Change 161.02% -44.39% 1335.55%
Operating Profit -$3.572M -$1.970M -$1.005M
YoY Change 255.46%
Interest Expense $0.00 $60.00K $0.00
YoY Change -700.0%
% of Operating Profit
Other Income/Expense, Net $54.00
YoY Change -101.24%
Pretax Income -$3.570M -$1.910M -$1.000M
YoY Change 257.0% -3.54% 1281.92%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$3.570M -$1.910M -$1.005M
YoY Change 255.28% -3.54% 1273.41%
Net Earnings / Revenue -4118.36% -2728.57%
Basic Earnings Per Share
Diluted Earnings Per Share -$3.43 -$2.06 -$2.32
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2018 Q1 2017 Q4 2017 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.500M $600.0K $3.100M
YoY Change -51.61% 0.0% 34.78%
Cash & Equivalents $1.519M $3.619M $3.114M
Short-Term Investments
Other Short-Term Assets $600.0K $3.200M $100.0K
YoY Change 500.0% 3100.0%
Inventory
Prepaid Expenses
Receivables $73.67K $53.20K
Other Receivables $0.00 $0.00
Total Short-Term Assets $2.200M $3.861M $3.230M
YoY Change -31.89% 436.33% 40.44%
LONG-TERM ASSETS
Property, Plant & Equipment $3.789M $2.688M $1.191M
YoY Change 218.03% 390.64%
Goodwill
YoY Change
Intangibles $32.28K $20.00K $20.00K
YoY Change 61.42% 0.0%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $4.800M $2.708M $1.211M
YoY Change 296.2% 376.88%
TOTAL ASSETS
Total Short-Term Assets $2.200M $3.861M $3.230M
Total Long-Term Assets $4.800M $2.708M $1.211M
Total Assets $7.000M $6.569M $4.442M
YoY Change 57.6% 410.12% 93.12%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $500.0K $162.3K $200.0K
YoY Change 150.0% 5.15%
Accrued Expenses $768.5K $222.7K $527.3K
YoY Change 45.74% 306.47%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.300M $416.4K $886.2K
YoY Change 46.69% 20.25% 786.23%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $0.00
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.300M $416.4K $886.2K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $1.278M $3.416M $900.0K
YoY Change 42.0% 886.48% 800.0%
SHAREHOLDERS EQUITY
Retained Earnings -$12.04M -$8.472M -$3.193M
YoY Change 277.25% 287.25%
Common Stock $302.2K $285.2K $220.6K
YoY Change 36.99% 29.34%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $5.539M $2.984M $3.600M
YoY Change
Total Liabilities & Shareholders Equity $6.985M $6.569M $4.442M
YoY Change 57.27% 410.12% 93.12%

Cashflow Statement

Concept 2018 Q1 2017 Q4 2017 Q1
OPERATING ACTIVITIES
Net Income -$3.570M -$1.910M -$1.005M
YoY Change 255.28% -3.54% 1273.41%
Depreciation, Depletion And Amortization $5.630K $290.0K $881.00
YoY Change 539.05%
Cash From Operating Activities -$1.789M -$1.540M -$535.5K
YoY Change 234.11% 136.92% 1684.9%
INVESTING ACTIVITIES
Capital Expenditures $560.0K $530.0K $430.0K
YoY Change 30.23% 23.26%
Acquisitions
YoY Change
Other Investing Activities -$1.000M $0.00
YoY Change -100.0%
Cash From Investing Activities -$1.561M -$530.0K -$432.4K
YoY Change 260.99% -201.92% -354.36%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $1.250M 3.980M $3.484M
YoY Change -64.12% 586.21%
NET CHANGE
Cash From Operating Activities -$1.789M -1.540M -$535.5K
Cash From Investing Activities -$1.561M -530.0K -$432.4K
Cash From Financing Activities $1.250M 3.980M $3.484M
Net Change In Cash -$2.100M 1.910M $2.516M
YoY Change -183.47% 324.44% 1697.18%
FREE CASH FLOW
Cash From Operating Activities -$1.789M -$1.540M -$535.5K
Capital Expenditures $560.0K $530.0K $430.0K
Free Cash Flow -$2.349M -$2.070M -$965.5K
YoY Change 143.31% 91.67%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q1 mven Future Minimum Sublease Rentals Within Four Years
FutureMinimumSubleaseRentalsWithinFourYears
227000 USD
CY2018Q1 us-gaap Other Commitment Due In Next Twelve Months
OtherCommitmentDueInNextTwelveMonths
405000 USD
CY2018Q1 us-gaap Common Stock Value
CommonStockValue
302159 USD
CY2018Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
17280641 USD
CY2017Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
222699 USD
CY2018Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3789288 USD
CY2018Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
32283 USD
CY2018Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
768483 USD
CY2017Q4 us-gaap Cash
Cash
619249 USD
CY2017Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
162308 USD
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2687727 USD
CY2017Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
20000 USD
CY2018Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-12044000 USD
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
5538800 USD
CY2018Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6985255 USD
CY2018Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
552876 USD
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
285159 USD
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-8472071 USD
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
2983754 USD
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6568694 USD
CY2017Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
174369 USD
CY2018Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
73671 USD
CY2017Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
53202 USD
CY2018Q1 us-gaap Deferred Costs Current
DeferredCostsCurrent
17955 USD
CY2017Q4 us-gaap Deferred Costs Current
DeferredCostsCurrent
14147 USD
CY2018Q1 us-gaap Deferred Revenue
DeferredRevenue
37149 USD
CY2017Q4 us-gaap Deferred Revenue
DeferredRevenue
31437 USD
CY2018Q1 mven Investor Demand Payablenoncurrent
InvestorDemandPayablenoncurrent
0 USD
CY2017Q4 mven Investor Demand Payablenoncurrent
InvestorDemandPayablenoncurrent
3000000 USD
CY2018Q1 us-gaap Liabilities
Liabilities
1277959 USD
CY2017Q4 us-gaap Liabilities
Liabilities
3416444 USD
CY2018Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2018Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
0 USD
CY2017Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
3000000 USD
CY2018Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2532502 USD
CY2018Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-3571929 USD
CY2018Q1 us-gaap Investment Income Net
InvestmentIncomeNet
0 USD
CY2018Q1 us-gaap Sales Revenue Net
SalesRevenueNet
86685 USD
CY2018Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
90404 USD
CY2018Q1 us-gaap Operating Expenses
OperatingExpenses
2622906 USD
CY2018Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.16
CY2018Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
22934369 shares
CY2017Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
940860 USD
CY2017Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1004882 USD
CY2017Q1 us-gaap Investment Income Net
InvestmentIncomeNet
54 USD
CY2017Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
54 USD
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
-1004828 USD
CY2017Q1 us-gaap Sales Revenue Net
SalesRevenueNet
0 USD
CY2017Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
64022 USD
CY2017Q1 us-gaap Operating Expenses
OperatingExpenses
1004882 USD
CY2017Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.11
CY2017Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
9537523 shares
CY2018Q1 us-gaap Cost Of Revenue
CostOfRevenue
1035708 USD
CY2017Q1 us-gaap Cost Of Revenue
CostOfRevenue
0 USD
CY2018Q1 us-gaap Gross Profit
GrossProfit
-949023 USD
CY2017Q1 us-gaap Gross Profit
GrossProfit
0 USD
CY2018Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3868105 USD
CY2018Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2258870 USD
CY2018Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1350892 USD
CY2018Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
310018 USD
CY2018Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1789058 USD
CY2018Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1561009 USD
CY2018Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
378506 USD
CY2018Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
163891 USD
CY2018Q1 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
561009 USD
CY2017Q1 us-gaap Share Based Compensation
ShareBasedCompensation
286149 USD
CY2017Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
74518 USD
CY2017Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-535471 USD
CY2017Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-432419 USD
CY2017Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-5716 USD
CY2017Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
102093 USD
CY2017Q1 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
432419 USD
CY2018Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
355142 USD
CY2017Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
881 USD
CY2018Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
20469 USD
CY2017Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
0 USD
CY2018Q1 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
3808 USD
CY2017Q1 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
0 USD
CY2018Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
5711 USD
CY2017Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
0 USD
CY2018Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1250000 USD
CY2017Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3483935 USD
CY2018Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2100067 USD
CY2017Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2516045 USD
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3619249 USD
CY2016Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
598294 USD
CY2018Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1519182 USD
CY2017Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3114339 USD
CY2016Q4 us-gaap Proceeds From Contributions From Parent
ProceedsFromContributionsFromParent
735099 USD
CY2018Q1 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
3000000 USD
CY2018Q1 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
1250000 USD
CY2018Q1 us-gaap Deferred Set Up Costs Current
DeferredSetUpCostsCurrent
17955 USD
CY2018Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34 pure
CY2018Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
12617957 shares
CY2018Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
880253 USD
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
525110 USD
CY2018Q1 us-gaap Depreciation
Depreciation
5630 USD
CY2017Q1 us-gaap Depreciation
Depreciation
881 USD
CY2018Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2016Q3 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
2952 USD
CY2016Q3 us-gaap Accelerated Share Repurchases Final Price Paid Per Share
AcceleratedShareRepurchasesFinalPricePaidPerShare
0.0002
CY2016Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
4.13607 pure
CY2018Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2018Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2018Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
30216009 shares
CY2018Q1 mven Percentage Of Escrow Shares To Be Released Subject To Performance Condition
PercentageOfEscrowSharesToBeReleasedSubjectToPerformanceCondition
0.56 pure
CY2018Q1 mven Recapitalization Number Of Shares Transfer To Escrow Account Subject To Buy Back Right
RecapitalizationNumberOfSharesTransferToEscrowAccountSubjectToBuyBackRight
1927641 shares
CY2018Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
2800000 USD
CY2018Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
502917 shares
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0 USD
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
225000 shares
CY2018Q1 mven Reclssification Of Sharebased Compensation To Website Development Costs
ReclssificationOfSharebasedCompensationToWebsiteDevelopmentCosts
907978 USD
CY2017Q1 mven Reclssification Of Sharebased Compensation To Website Development Costs
ReclssificationOfSharebasedCompensationToWebsiteDevelopmentCosts
212156 USD
CY2017Q2 us-gaap Share Price
SharePrice
1.00
CY2017Q2 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
3765000 USD
CY2018Q1 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
735000 USD
CY2018Q1 mven Future Minimum Sublease Rentals Next Twelve Months
FutureMinimumSubleaseRentalsNextTwelveMonths
113000 USD
CY2018Q1 mven Future Minimum Sublease Rentals Within Two Years
FutureMinimumSubleaseRentalsWithinTwoYears
233000 USD
CY2018Q1 us-gaap Other Commitment Due In Second Year
OtherCommitmentDueInSecondYear
142000 USD
CY2018Q1 mven Aggregate Remaining Commitment
AggregateRemainingCommitment
547000 USD
CY2018Q1 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
500000 USD
CY2018Q1 mven Future Minimum Sublease Rentals Within Three Years
FutureMinimumSubleaseRentalsWithinThreeYears
265000 USD
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2018Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
30216009 shares
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28516009 shares
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
28516009 shares
CY2018Q1 us-gaap Nature Of Operations
NatureOfOperations
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"><b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font>1. Nature of Operations</b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify">TheMaven, Inc. (&#8220;Parent&#8221;) and Maven Coalition, Inc. (&#8220;Subsidiary&#8221;) (collectively &#8220;TheMaven&#8221; or the &#8220;Company&#8221;) are developing an exclusive network of professionally managed online media channels, with an underlying technology platform. Each channel will be operated by an invite only Channel Partner drawn from subject matter experts, reporters, group evangelists and social leaders. Channel Partners will publish content and oversee an online community for their respective channels, leveraging a proprietary, socially-driven, mobile-enabled, video-focused technology platform to engage niche audiences within a single network.</div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2018Q1 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
1000000 USD
CY2017Q4 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
0 USD
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2018Q1 us-gaap Increase Decrease In Notes Receivable Current
IncreaseDecreaseInNotesReceivableCurrent
1000000 USD
CY2017Q1 us-gaap Increase Decrease In Notes Receivable Current
IncreaseDecreaseInNotesReceivableCurrent
0 USD
CY2017Q1 mven Accrual Of Stock Issuance Costs
AccrualOfStockIssuanceCosts
363219 USD
CY2018Q1 mven Accrual Of Stock Issuance Costs
AccrualOfStockIssuanceCosts
381895 USD
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.83
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3652887 shares
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
1347113 shares
CY2018Q1 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
5000000 shares
CY2018Q1 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
1250000 USD
CY2017Q1 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
3483935 USD
CY2018Q1 us-gaap Other Commitment
OtherCommitment
547000 USD
CY2018Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
349512 USD
CY2017Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
0 USD
CY2018Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"><i>Use of Estimates</i></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses for the reporting period.&#160;&#160;Actual results could materially differ from those estimates.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2018Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4669541 USD
CY2017Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3212837 USD
CY2018Q1 mven Future Minimum Sublease Expenses Total
FutureMinimumSubleaseExpensesTotal
838000 USD
CY2018Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2018Q1 mven Payments Of Guarantees Obligation
PaymentsOfGuaranteesObligation
406286 USD
CY2017Q1 mven Payments Of Guarantees Obligation
PaymentsOfGuaranteesObligation
45000 USD
CY2018Q1 mven Classification Of Share Based Compensation To Web Site Development Costs
ClassificationOfShareBasedCompensationToWebSiteDevelopmentCosts
907978 USD
CY2017Q1 mven Classification Of Share Based Compensation To Web Site Development Costs
ClassificationOfShareBasedCompensationToWebSiteDevelopmentCosts
212156 USD
CY2017Q1 mven Reclassification Of Investor Note Payable To Common Stock To Be Issued
ReclassificationOfInvestorNotePayableToCommonStockToBeIssued
0 USD
CY2018Q1 mven Reclassification Of Investor Note Payable To Common Stock To Be Issued
ReclassificationOfInvestorNotePayableToCommonStockToBeIssued
3000000 USD
CY2018Q1 us-gaap Basis Of Accounting
BasisOfAccounting
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font>2. Basis of Presentation</b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify">TheMaven Network, Inc. was incorporated in Nevada on July 22, 2016, under the name &#8220;Amplify Media, Inc.&#8221; On July 27, 2016, the corporate name was amended to &#8220;Amplify Media Network, Inc.&#8221; and on October 14, 2016, the corporate name was changed to &#8220;TheMaven Network, Inc.&#8221; On March 5, 2018 the corporate name was changed to Maven Coalition, Inc.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify">TheMaven, Inc. was formerly known as Integrated Surgical Systems, Inc., a Delaware corporation (&#8220;<i>Integrated</i>&#8221;). From June 2007 until November 4, 2016, Integrated was a non-active &#8220;shell company&#8221; as defined by regulations of the Securities and Exchange Commission (SEC). On August 11, 2016, Integrated entered into a loan to Subsidiary that provided initial funding totaling $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">735,099</font> for the Subsidiary&#8217;s operations. On October 14, 2016 Integrated entered into a Share Exchange Agreement (the &#8220;<i>Share Exchange Agreement</i>&#8221;) with Subsidiary and the shareholders of Subsidiary, holding all of the issued and outstanding shares of Subsidiary (collectively, &#8220;<i>Subsidiary Shareholders</i>&#8221;). The Share Exchange Agreement was amended on November 4, 2016 to include certain newly issued shares of Subsidiary in the transaction and make related changes to the agreement and the Share Exchange was consummated. The transaction resulted in Parent acquiring Subsidiary by the exchange of all of the outstanding shares of Subsidiary for <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 12,517,152</font> newly issued shares of the common stock, $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">0.01</font> par value (the &#8220;<i>Common Stock</i>&#8221;) of Parent, representing approximately <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 56.7</font>% of the issued and outstanding shares of Common Stock immediately after the transaction. The transaction is referred to as the &#8220;Recapitalization.&#8221; The Recapitalization was consummated on November 4, 2016, as a result of which Maven Coalition, Inc. became a wholly owned subsidiary of Integrated (the &#8220;<i>Closing</i>&#8221;). The note payable between Integrated and Subsidiary was an interdependent transaction with the Recapitalization and was ultimately cancelled upon closing of the Recapitalization. On December 2, 2016, Integrated amended its Certificate of Incorporation to change its name from &#8220;Integrated Surgical Systems, Inc.&#8221; to &#8220;TheMaven, Inc.&#8221;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify">From June 2007 until the closing of the Recapitalization, Integrated was a non-active &#8220;shell company&#8221; as defined by regulations of the SEC and, accordingly, the Recapitalization was accounted for as a reverse recapitalization rather than a business combination. As the Subsidiary is deemed to be the purchaser for accounting purposes under reverse recapitalization accounting, the Company&#8217;s financial statements are presented as a continuation of Subsidiary, and the accounting for the Recapitalization is equivalent to the issuance of stock by Subsidiary for the net monetary assets of Parent as of the Closing accompanied by a recapitalization. &#160;See Note 9 for summary of the assets acquired, transaction costs and the consideration exchanged in the Recapitalization.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify">The financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;) and applicable rules and regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;). Our unaudited condensed financial statements reflect all adjustments, which are, in the opinion of management, necessary for a fair presentation of our financial position and results of operations. Such adjustments are of a normal recurring nature, unless otherwise noted. The balance sheet as of March 31, 2018 and the results of operations for the three months ended March 31, 2018 are not necessarily indicative of the results to be expected for the entire year.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2018Q1 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
1250000 USD
CY2018Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1200000 shares
CY2018Q1 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
2.50
CY2018Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
500000 shares
CY2018Q1 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
2.50
CY2018Q1 us-gaap Reclassifications
Reclassifications
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"><i>Reclassifications</i></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify">Certain reclassifications have been made to the prior period financial statements to conform to the current period presentation. These reclassifications did not result in any changes in total assets, liabilities, stockholders&#8217; equity, or net loss.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2018Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y3M18D

Files In Submission

Name View Source Status
0001144204-18-036123-index-headers.html Edgar Link pending
0001144204-18-036123-index.html Edgar Link pending
0001144204-18-036123.txt Edgar Link pending
0001144204-18-036123-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
mven-20180331.xml Edgar Link completed
mven-20180331.xsd Edgar Link pending
mven-20180331_cal.xml Edgar Link unprocessable
mven-20180331_def.xml Edgar Link unprocessable
mven-20180331_lab.xml Edgar Link unprocessable
mven-20180331_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tv495098_10q.htm Edgar Link pending
tv495098_ex31-1.htm Edgar Link pending
tv495098_ex31-2.htm Edgar Link pending
tv495098_ex32-1.htm Edgar Link pending
tv495098_ex32-2.htm Edgar Link pending